Navigation Links
Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death

Tell your doctor if you have liver disease, or if you experience unexplained tiredness, stomach problems, dark urine or yellowing of skin while taking Avandia.

Tell your doctor about all of the medicines you are taking. If you are taking Avandia with another diabetes medicine that lowers blood sugar, you may be at increased risk for low blood sugar. Ask your doctor whether you need to lower the dose of your other diabetes medicine.

Avandia may increase your risk of pregnancy. Talk to your doctor before taking Avandia if you could become pregnant or if you are pregnant. If you are nursing, you should not take Avandia. Talk to your doctor for advice on how to keep your bones healthy. More fractures, usually in the upper arm, hand, or foot, have been seen in women taking Avandia. Your doctor should check your eyes regularly. Very rarely, some people have experienced vision changes due to swelling in the back of the eye while taking Avandia.

CONTACT: US Media, Nancy Pekarek +1-215-751-7709, or Mary Anne Rhyne,+1-919-483-2839, or Alice Hunt, +1-215-751-7709, UK Media, Phil Thomson,Joss Mathieson, or Gwenan White, +020-8047-5502, or US Analysts, InvestorsFrank Murdolo, +1-215-751-7002, or Tom Curry, +1-215-751-5419, or EuropeanAnalysts, Investors, Anita Kidgell, +020-8047-5542, or David Mawdsley,+020-8047-5564, or Sally Ferguson, +020-8047-5543

Web site: http://www.gsk.com/

Company News On-Call: http://www.prnewswire.com/comp/801350.html /

Ticker Symbol: (NYSE:GSK)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting

Post Your Comments:
(Date:11/25/2009)..., HARBIN, China, Nov. 25 /PRNewswire-Asia-F...ky One Medical" or "the Company") (Nasdaq: CSKI )...y developing and producing,over-the-counter drugs ...nnounced that the Company recently passed the Chin...utical and Biological Products ("ICPBP") examinati...
(Date:11/25/2009)..., EAST BRUNSWICK, N.J., Nov. 25 S... of direct digital Radiography ( ddR ) systems, an...ed by a private Swiss Investor with a long term vi...d. The acquisition included all assets and intelle.... After 25 years of success and growth Swissray is...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Pain Manag...nker.com/p0164220/Pain-Management---Global-Trends....gs, emergence of pain management clinics, and the ...rowth in the pain management market. Healthcare re...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 1Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 2Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 3Herbicide diversity needed to keep Roundup effective 9243 1Herbicide diversity needed to keep Roundup effective 9243 2Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 1Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 2
...d Community Oncology Research Network, Inc. Surpas...MEMPHIS, Tenn., March 31 The Accelerated Communit...nal oncology clinical trial,network, announced tod...xceeded performance expectations over the past 12 ...earch services to sponsors, from clinical,trial de...
... of Target Enrollment Expected in Fourth Quarter, ...ted (Nasdaq: GNTA ) announced that the Data Safet...ial of Genasense (oblimersen sodium),Injection, wh...commended,that the trial be continued as originall...ata from the study., AGENDA is a Phase 3, randomi...
Other Medicine Technology:ACORN's Oncology-focused Contract Research Organization Exceeds Projections 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is grea... Weil, M.D., author and physician best known for e...ive medicine. Go to www.yogaforce.com and order...ift list. , San Francisco... the holidays, the YogaForce newly patented, revol...
(Date:11/28/2009)...Nov. 28 Get ready for advanced ...nical routine when Siemens introduces syngo...nnual Meeting of the Radiological Society of North...McCormick Place (Booth #825, East Building/Lakesid... , Siemens, new imaging software for multimodal...
(Date:11/28/2009)...elp lift spirits, recognize signs of depression ,...For many seniors, the holiday season can trigger m...uggle with health issues or worry about money prob.... , To help overcome the seasonal blues, the AG...ing advice: , Get out and socialize or invite fa...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its la...c data. It shows that the lethality of the virus ... the virus,s current outbreak in the spring of 200...(s.d. 0.1). The H1N1 infectivity count, however, r...n (PRWEB) November 27, 2009 -- Biotech firm Replik...
(Date:11/27/2009)...N.Y., Nov. 27 Preventin...r and fortunately every year, new vaccines are bei...ll vaccines boost immunity for the same period of ...ots, needed to keep immunity strong? ,, In th... American Academy of Pediatrics, Michael Pichicher...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
...nsion journal suggests that increasing, dietary ...revention of hypertension, a major pu...e good sources of potassium and low in sodium ...Hypertension,concludes that an increase in potassi...
...olecular "smart bombs" to target metastasis with a...ficantly lower doses of toxic chemotherapy, with l...ding to a collaborative team of researchers at the...ector of Translational Research David Cheresh, Ph....
...ty HealthSystem,Consortium (UHC), welcomes Susan K...Chief Learning Officer. Dr. Pingleton has more tha...cine and comes to UHC from The,University of Kansa... Scholar in Residence at the Association of,Americ...
...sk for psychiatric disorders, study finds , ...lone isn,t associated with an increased risk of me...en suggested that pregnant women and those who,ve ...he study. , To determine whether this was true, th...
... trusted and,accessible health care providers, pha... and make more than 80 million recommendations to ...tients will follow these,recommendations. In fact,... purchase a particular OTC medicine based on,their...
...ny,(Nasdaq: PRGO ;TASE) announced today that Jose...t at the Oppenheimer & Co. Inc. 8th Annual Consume...m. (ET) at the Four Seasons,Hotel in Boston. The p...l healthcare supplier that develops,manufactures a...
Other Medicine News:Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 3Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 4Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 5Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2Health News:Pregnancy Alone Not A Risk for Mental Health Problems 2
SureStep LH
Clearview Exact Strep A Dipstick
Clearview Exact Strep A Cassette
Inverness Medical Testpack+Plus Strep A with OBC (20 Tests)
Medicine Products: